Works matching IS 10538569 AND DT 2023 AND VI 32 AND IP 9
Results: 13
Evaluating the use of methods to mitigate bias from non‐transient medications in the case‐crossover design: A systematic review.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 9, p. 939, doi. 10.1002/pds.5649
- By:
- Publication type:
- Article
Mifepristone and the courts: The thread that could unravel regulation of drugs in the United States.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 9, p. 1049, doi. 10.1002/pds.5642
- By:
- Publication type:
- Article
Distribution of gestational age at birth by maternal and infant characteristics in U.S. birth certificate data: Informing gestational age assumptions when clinical estimates are not available.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 9, p. 1012, doi. 10.1002/pds.5633
- By:
- Publication type:
- Article
Bias in observational studies on the effectiveness of in hospital use of hydroxychloroquine in COVID‐19.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 9, p. 1001, doi. 10.1002/pds.5632
- By:
- Publication type:
- Article
Assessing heterogeneity of electronic health‐care databases: A case study of background incidence rates of venous thromboembolism.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 9, p. 1032, doi. 10.1002/pds.5631
- By:
- Publication type:
- Article
Real‐world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 9, p. 988, doi. 10.1002/pds.5630
- By:
- Publication type:
- Article
Signal detection of COVID‐19 vaccines adverse events using spontaneous reports from South Korea.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 9, p. 961, doi. 10.1002/pds.5629
- By:
- Publication type:
- Article
Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learned.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 9, p. 969, doi. 10.1002/pds.5627
- By:
- Publication type:
- Article
Hypertension medication from guidelines to practice: A cohort study in western Iran.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 9, p. 951, doi. 10.1002/pds.5626
- By:
- Publication type:
- Article
Virological failure and its predictors among human immunodeficiency virus infected individuals on second line antiretroviral treatment in North‐East Ethiopia, 2021.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 9, p. 978, doi. 10.1002/pds.5625
- By:
- Publication type:
- Article
Feasibility and validity of using healthcare databases to conduct cross‐national comparative studies of opioid use, its determinants and consequences.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 9, p. 1021, doi. 10.1002/pds.5618
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 9, p. 1052, doi. 10.1002/pds.5470
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 9, p. 1, doi. 10.1002/pds.5469
- Publication type:
- Article